Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus
Status:
Withdrawn
Trial end date:
2021-05-18
Target enrollment:
Participant gender:
Summary
The study will investigate the efficacy of the N-methyl-D-aspartate receptor antagonist
ketamine as a first line agent in refractory status epilepticus versus traditional general
anesthetic agents used for burst suppression that target the gamma-aminobutyric acid
adrenergic receptors.